Key Takeaways
- • North Fork Commercial brokered the acquisition of MiMedx Group's 79,854-square-foot corporate headquarters and research facility in Marietta, Georgia, representing the buyer in the transaction.
- • The asset is a single-tenant, fully-leased life sciences property occupied by Nasdaq-listed biopharmaceutical company MiMedx Group, Inc. (MDXG), which specializes in regenerative medicine and placental tissue products, providing long-term tenant credit quality.
- • The two-story facility, constructed in 1993 and situated on over seven acres with 291 parking spaces at 1775 W. Oak Commons Court, includes specialized laboratory and clean-room space, warehouse infrastructure with loading dock capabilities, and executive office areas supporting mission-critical research operations.
- • Kristopher J. Pilles, Founder and Broker of North Fork Commercial, characterized the acquisition as a "rare opportunity" combining specialized facility improvements, credit-worthy long-term tenancy, and favorable market fundamentals in a supply-constrained Atlanta life sciences submarket, positioning it as a strategic long-term hold.
Summary
North Fork Commercial, a boutique commercial real estate brokerage, facilitated the acquisition of MiMedx Group's corporate headquarters and research facility in Marietta, Georgia, representing the buyer in the transaction. The 79,854-square-foot property represents a significant institutional investment in specialized life sciences real estate within the Atlanta metropolitan market.
The asset qualifies as mission-critical infrastructure for MiMedx Group, Inc. (Nasdaq: MDXG), a biopharmaceutical company focused on regenerative medicine and placental tissue products. The single-tenant structure with full occupancy by the Nasdaq-listed tenant provides stable, long-term cash flow with demonstrated credit quality typical of publicly-traded tenants.
The facility, located at 1775 W. Oak Commons Court, was originally constructed in 1993 and encompasses two stories on a 7-acre parcel with 291 parking spaces. The property's design reflects specialized life sciences requirements, including laboratory and clean-room space, warehouse areas equipped with roll-up doors and loading dock facilities, and dedicated executive office and conference spaces. These improvements support both corporate operations and active research activities.
According to Kristopher J. Pilles, Founder and Broker of North Fork Commercial, the acquisition represents a "rare opportunity" in a highly constrained submarket. The combination of purpose-built specialization, established tenant stability, and favorable Atlanta market dynamics positioned the asset as an attractive long-term hold for institutional investors seeking exposure to life sciences real estate with predictable tenant performance.
The asset qualifies as mission-critical infrastructure for MiMedx Group, Inc. (Nasdaq: MDXG), a biopharmaceutical company focused on regenerative medicine and placental tissue products. The single-tenant structure with full occupancy by the Nasdaq-listed tenant provides stable, long-term cash flow with demonstrated credit quality typical of publicly-traded tenants.
The facility, located at 1775 W. Oak Commons Court, was originally constructed in 1993 and encompasses two stories on a 7-acre parcel with 291 parking spaces. The property's design reflects specialized life sciences requirements, including laboratory and clean-room space, warehouse areas equipped with roll-up doors and loading dock facilities, and dedicated executive office and conference spaces. These improvements support both corporate operations and active research activities.
According to Kristopher J. Pilles, Founder and Broker of North Fork Commercial, the acquisition represents a "rare opportunity" in a highly constrained submarket. The combination of purpose-built specialization, established tenant stability, and favorable Atlanta market dynamics positioned the asset as an attractive long-term hold for institutional investors seeking exposure to life sciences real estate with predictable tenant performance.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.